Tuesday's Washington Post featured an editorial by pharmaceutical giant Wyeth Corps president, executive and chairman Robert Essner, Open the Door to Curing Alzheimers: Why This Research Must Become an Urgent Priority. His article appealed to researchers, regulators and industry leaders to work toward finding a cure for Alzheimers disease. He emphasized the urgency of a collaborative effort, arguing that the failure to make this disease a number one priority will have implications of epidemic proportions.
Expert Caregiver Jacqueline Marcell, author of Elder Rage, Expert Caregiver Carol Bradley Bursack, author of Minding Our Elders: Caregivers Share Their Personal Stories, expert caregiver and journalist Dorian Martin, and caregiver expert Lynne Taetzsch, author of The Bipolar Dementia Art Chronicles: How a Manic-Depressive Artist Survives Being the Primary Caregiver for Her Father and Ex-Mother-in-Law share their insights on this piece and what you need to know about the state of Alzheimer's research.
Jacqueline Marcell, author of Elder Rage:
"This is an excellent and accurate article, emphasizing the importance of early diagnosis and treatment of Alzheimers disease--and the extreme urgency of finding a cure. Since taking care of two parents with AD for five years, that is my fulltime mission too, as there is no time to waste. Unfortunately, the public may suspect ulterior motives, since the article is written by the Chairman of Wyeth Corporation a pharmaceutical company. Actually, I bless the drug companies, because I saw such an improvement in my parents when I was finally able to get one of the medications to slow the progression of the disease. When it is your loved one who is clearerthat is huge. After decades in which multi-millions of dollars have been spent on scientific research to try to find the complicated answers to this horrible disease, I think the drug company that finally finds the cure--deserves everything it gets."